A prospective study of 20 foot and ankle wounds treated with cryopreserved amniotic membrane and fluid allograft

Journal of Foot and Ankle Surgery

Volumn 52, Issue 5, 2013, Pages 615-621

  Werber, Bruce ^a   Martin, Erin ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b InMotion Foot and Ankle Specialists   (United States)

Author keywords

Amnion; Debridement; Growth factor; Skin; Wound healing

Indexed keywords

ADULT; AGED; ALLOGRAFT; ALLOTRANSPLANTATION; AMNION; AMNION FLUID; AMPUTATION; ARTICLE; BONE DEFECT; CHRONIC WOUND; CLINICAL ARTICLE; CLINICAL OBSERVATION; CRYOPRESERVATION; DIABETIC FOOT; FOLLOW UP; GRANULIZED AMNIOTIC MEMBRANE AND AMNIOTIC FLUID ALLOGRAFT; HUMAN; MALE; PROSPECTIVE STUDY; SOFT TISSUE DEFECT; TREATMENT DURATION; WOUND CARE; WOUND HEALING;

4; AMNION; DEBRIDEMENT; GROWTH FACTOR; SKIN; WOUND HEALING;

AGED; AGED, 80 AND OVER; ALLOGRAFTS; AMNION; AMNIOTIC FLUID; CRYOPRESERVATION; DEBRIDEMENT; DIABETIC FOOT; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; WOUND HEALING;

EID: 84882690163     PISSN: 10672516     EISSN: 15422224     Source Type: Journal    
DOI: 10.1053/j.jfas.2013.03.024     Document Type: Article

References (62)

1. Scheubel R.J., Zorn H., Silber R.E., Kuss O., Morawietz H., Holtz J., Simm A. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003, 42:2073-2080.
2. Sakuragawa N., Kakinuma K., Kikuchi A., Okano H., Uchida S., Kamo I., Kobayashi M., Yokoyama Y. Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells. J Neurosci Res 2004, 78:208-214.
3. Horwitz E.M., Le Blanc K., Dominici M., Mueller I., Slaper-Cortenbach I., Marini F.C., Deans R.J., Krause D.S., Keating A. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 2005, 7:393-395.
4. Modesti A., Scarpa S., D'Orazi G., Simonelli L., Caramia F.G. Localization of type IV and V collagens in the stroma of human amnion. Progr Clin Biol Res 1989, 296:459-463.
5. Fukuda K., Chikama T., Nakamura M., Nishida T. Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva. Cornea 1999, 18:73-79.
6. Koizumi N.J., Inatomi T.J., Sotozono C.J., Fullwood N.J., Quantock A.J., Kinoshita S. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res 2000, 20:173-177.
7. Trelford J.D., Trelford-Sauder M. The amnion in surgery, past and present. Am J Obstet Gynecol 1979, 134:833-845.
8. Colocho G., Graham W.P., Greene A.E., Matheson D.W., Lynch D. Human amniotic membrane as a physiologic wound dressing. Arch Surg 1974, 109:370-373.
9. Prasad J.K., Feller I., Thomson P.D. Use of amnion for the treatment of Stevens-Johnson syndrome. J Trauma 1986, 26:945-946.
10. Subrahmanyam M. Amniotic membrane as a cover for microskin grafts. Br J Plast Surg 1995, 48:477-478.
11. Cheung C.Y. Vascular endothelial growth factor activation of intramembranous absorption: a critical pathway for amniotic fluid volume regulation. J Soc Gynecol Investig 2004, 11:63-74.
12. Moshiri A., Oryan A. Structural and functional modulation of early healing of full-thickness superficial digital flexor tendon rupture in rabbits by repeated subcutaneous administration of exogenous human recombinant basic fibroblast growth factor. J Foot Ankle Surg 2011, 50:654-662.
13. Yoshio H., Tollin M., Gudmundsson G.H. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr Res 2003, 53:211-216.
14. Espinoza J., Chaiworapongsa T., Romero R. Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J Matern Fetal Neonatal Med 2003, 13:2-21.
15. Akinbi H.T., Narendran V., Pass A.K., Markart P., Hoath S.B. Host defense proteins in vernix caseosa and amniotic fluid. Am J Obstet Gynecol 2004, 191:2090-2096.
16. Otsuki K., Yoda A., Saito H., Mitsuhashi Y., Shimizu Y., Yanaiha T. Amniotic fluid lactoferrin in intrauterine infection. Placenta 1999, 20:175-179.
17. Ozgenel G.Y., Filiz G. Effects of human amniotic fluid on peripheral nerve scarring and regeneration in rats. J Neurosurg 2003, 98:371-377.
18. Gao X., Devoe L.D., Given K.S. Effects of amniotic fluid on proteases: a possible role of amniotic fluid in fetal wound healing. Ann Plast Surg 1994, 33:128-134. discussion 134-135.
19. Tsai M.S., Lee J.L., Chang Y.J., Hwang S.M. Isolation of human multipotent mesenchymal stem cells from second trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004, 19:1450-1456.
20. In't Anker P.S., Scherjon S.A., Kleijburg-van der Keur C., de Groot-Swings G.M., Claas F.H., Fibbe W.E., Kanhai H.H. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004, 22:1338-1345.
21. Heil M., Eitenmüller I., Schmitz-Rixen T., Schaper W. Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med 2006, 10:45-55.
22. Davis J.W. Skin transplantation with a review of 550 cases at the Johns Hopkins Hospital. Johns Hopkins Med J 1910, 15:307-396.
23. Sabella N. Use of fetal membranes in skin grafting. Med Records NY 1913, 83:478-480.
24. Faulk W.P., Matthews R., Stevens P.J., Bennett J.P., Burgos H., Hsi B.L. Human amnion as an adjunct in wound healing. Lancet 1980, 1:1156-1158.
25. Kim J.C., Tseng S.C. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 1995, 14:473-484.
26. Koh J.W., Shin J.W., Oh J.Y., Kim M.K., Ko J.H., Hwang J.M., Wee W.R., Lee J.H. The expression of TIMPs in cryo-preserved and freeze dried amniotic membrane. Curr Eye Res 2007, 32:611-616.
27. Gruss J.S. Human amniotic membrane: a versatile wound dressing. Can Med Assoc J 1978, 118:1237-1246.
28. Adinolfi M. HLA typing of amniotic fluid cells. Prenat Diagn 1982, 2:147.
29. Adinolfi M., Akle C.A., McColl I., Fensom A.H., Tansley L., Connolly P., Hsi B.L., Faulk W.P., Travers P., Bodmer W.F. Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells. Nature 1982, 295:325-327.
30. Akle C.A., Adinolfi M., Welsh K.I., Leibowitz S., McColl I. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet 1981, 2:1003-1005.
31. Delo D.M., De Coppi P., Bartsch G., Atala A. Amniotic fluid and placental stem cells. Methods Enzymol 2006, 419:426-438.
32. Trelford J.D., Trelford-Sauder M. The amnion in surgery, past and present. Am J Obstet Gynecol 1979, 134:833-845.
33. Ucakhan O.O., Koklu G., Firat E. Nonpreserved human amniotic membrane transplantation in acute and chronic chemical eye injuries. Cornea 2002, 21:169-172.
34. Akle C.A., Adinolfi M., Welsh K.I. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet 1981, 2:1003-1005.
35. Solomon A., Wajngarten M., Alviano F., Anteby I., Elchalal U., Pe'er J., Levi-Schaffer F. Suppression of inflammatory and fibrotic responses in an in-vitro model of allergic inflammation by the amniotic membrane stromal matrix. Clin Exp Allergy 2005, 35:941-948.
36. Perin L., Sedrakyan S., Da Sacco S., De Filippo R. Characterization of human amniotic fluid stem cells and their pluripotential capability. Methods Cell Biol 2008, 86:85-99.
37. Zhang Y., Li C., Jiang X., Zhang S., Wu Y., Liu B., Tang P., Mao N. Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells. Exp Hematol 2004, 32:657-664.
38. Pasquinelli G., Tazzari P., Ricci F., Orrico C., Vaselli C., Buzzi M., Foroni L., Alviano F., Lucarelli E., Bagnara G.P., Stella A., Conte R. Ultrastructural characteristics of human mesenchymal stromal (stem) cells derived from bone marrow and term placenta. Ultrastruct Pathol 2007, 31:23-31.
39. Bailo M., Soncini M., Vertua E., Signoroni P.B., Sanzone S., Lombardi G., Arienti D., Calamani F., Zatti D., Paul P., Albertini A., Zorzi F., Cavagnini A., Candotti F., Wengler G.S, Parolini O. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 2004, 78:1439-1448.
40. Loh Y.H., Wu Q., Chew J.L., Vega V.B., Zhang W., Chen X., Bourque G., George J., Leong B., Liu J., Wong K.Y., Sung K.W., Lee C.W., Zhao X.D., Chiu K.P., Lipovich L., Kuznetsov V.A., Robson P., Stanton L.W., Wei C.L., Ruan Y., Lim B., Ng H.H. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006, 38:431-440.
41. Brichard S.M., Delporte M.L., Lambert M. Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm Metab Res 2003, 35:337-342.
42. Jones K.R., Fennie K., Lenihan A. Evidence-based management of chronic wounds. Adv Skin Wound care 2007, 20:591-600.
43. Carter M.J., Fife C.E., Walker D., Thomson B. Estimating the applicability of wound care randomized controlled trials to general wound-care populations by estimating the percentage of individuals excluded from a typical wound-care population in such trials. Adv Skin Wound Care 2009, 22:316-324.
44. Hunt T.K., La Van F.B. Enhancement of wound healing by growth factors. N Engl J Med 1989, 321:111-112.
45. Braund R., Hook S., Medlicott N.J. The role of topical growth factors in chronic wounds. Curr Drug Deliv 2007, 4:195-204.
46. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003, 83:835-870.
47. Barrientos S., Stojadinovic O., Golinko M.S., Brem H., Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008, 16:585-601.
48. Singer A.J., Clark R.A. Cutaneous wound healing. N Engl J Med 1999, 341:738-746.
49. Everts P.A., Brown Mahoney C., Hoffmann J.J., Schonberger J.P., Box H.A., van Zundert A., Knape J.T. Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release. Growth Factors 2006, 24:165-171.
50. Steed D.L., Goslen J.B., Holloway G.A., Malone J.M., Bunt T.J., Webster M.W. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers: CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care 1992, 15:1598-1604.
51. Knighton D.R., Fiegel V.D. Regulation of cutaneous wound healing by growth factors and the microenvironment. Investig Radiol 1991, 26:604-611.
52. Knighton D.R., Ciresi K., Fiegel V.D., Schumerth S., Butler E., Cerra F. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 1990, 170:56-60.
53. Keyser J.E. Diabetic wound healing and limb salvage in an outpatient wound care program. South Med J 1993, 86:311-317.
54. Glover J.L., Weingarten M.S., Buchbinder D.S., Poucher R.L., Deitrick G.A., Fylling C.P. A 4-year outcome-based retrospective study of wound healing and limb salvage in patients with chronic wounds. Adv Wound Care 1997, 10:33-38.
55. Atri S.C., Misra J., Bisht D., Misra K. Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers. Surgery 1990, 108:508-512.
56. Anitua E., Andia I., Ardanza B., Nurden P., Nurden A.T. Autologous platelets asa source of proteins for healing and tissue regeneration. Thromb Haemost 2004, 91:4-15.
57. Prusa A.R., Marton E., Rosner M., Bernaschek G., Hengstschlager M. Oct4-expressing cells in human amniotic fluid: a new source for stem cell research?. Hum Reprod 2003, 18:1489-1493.
58. Shearer A., Scuffham P., Gordois A., Oglesby A. Predicted costs and outcomes from reduced vibration detection in people with diabetes in the U.S. Diabetes Care 2003, 26:2305-2310.
59. Stute N., Holtz K., Bubenheim M., Lange C., Blake F., Zander A.R. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 2004, 32:1212-1225.
60. Deans R.J., Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000, 28:875-884.
61. Liu L., Sun Z., Chen B., Han Q., Liao L., Jia M., Cao Y., Ma J., Sun Q., Guo M., Liu Z., Ai H., Zhao R.C. Exvivo expansion and invivo infusion of bone marrow-derived Flk-1+CD31-CD34- mesenchymal stem cells: feasibility and safety from monkey to human. Stem Cells Dev 2006, 15:349-357.
62. Hollander A.P., Dickinson S.C., Sims T.J., Brun P., Cortivo R., Kon E., Marcacci M., Zanasi S., Borrione A., De Luca C., Pavesio A., Soranzo C., Abatangelo G. Maturation of tissue engineered cartilage implanted in injured and osteoarthritic human knees. Tissue Eng 2006, 12:1787-1798.